These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11132728)

  • 41. Photoreactivity of furocoumarins and DNA in PUVA therapy: formation of psoralen-thymine adducts.
    Serrano-Pérez JJ; Merchán M; Serrano-Andrés L
    J Phys Chem B; 2008 Nov; 112(44):14002-10. PubMed ID: 18855465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photocarcinogenicity of psoralens used in PUVA treatment: present status in mouse and man.
    Young AR
    J Photochem Photobiol B; 1990 Jun; 6(1-2):237-47. PubMed ID: 2121937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of PUVA on expression of Fas and FasL in inducing apoptosis of NB4 and K562 cells].
    Chen NN; Zhang GY; Xiang Y; Zhang L; Zhang DJ; Huang SL
    Zhong Yao Cai; 2009 Jan; 32(1):78-82. PubMed ID: 19445127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minimising the risks of PUVA treatment.
    van Praag MC; Tseng LN; Mommaas AM; Boom BW; Vermeer BJ
    Drug Saf; 1993 May; 8(5):340-9. PubMed ID: 8504016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vitamin D and psoralen plus UVA radiation.
    Mascaró JM
    Cutis; 2002 Nov; 70(5 Suppl):13-5. PubMed ID: 12467334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Products of psoralen photooxidation possess immunomodulative and antileukemic effects.
    Potapenko AYa ; Kyagova AA; Bezdetnaya LN; Lysenko EP; Chernyakhovskaya IYu ; Bekhalo VA; Nagurskaya EV; Nesterenko VA; Korotky NG; Akhtyamov SN
    Photochem Photobiol; 1994 Aug; 60(2):171-4. PubMed ID: 7938216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of DNA-psoralen photoadducts in mammalian skin.
    Pathak MA; Zarebska Z; Mihm MC; Jarzabek-Chorzelska M; Chorzelski T; Jablonska S
    J Invest Dermatol; 1986 Mar; 86(3):308-15. PubMed ID: 2427607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Skin phototoxicity variations during repeated bath PUVA exposures to 8-methoxypsoralen and trimethylpsoralen.
    Koulu LM; Jansén CT
    Clin Exp Dermatol; 1984 Jan; 9(1):64-9. PubMed ID: 6692588
    [No Abstract]   [Full Text] [Related]  

  • 49. Psoralens potentiate ultraviolet light-induced inhibition of epidermal growth factor binding.
    Laskin JD; Lee E; Laskin DL; Gallo MA
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8211-5. PubMed ID: 3490664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutaneous phototoxicity due to psoralens.
    Gange RW; Parrish JA
    Natl Cancer Inst Monogr; 1984 Dec; 66():117-26. PubMed ID: 6531018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psoralen photoinactivation of herpes simplex virus: monoadduct and cross-link repair by xeroderma pigmentosum and Fanconi's anemia cells.
    Fendrick JL; Hallick LM
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):96s-101s. PubMed ID: 6330231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic immunosuppression of cell-mediated immune reactions by a monofunctional psoralen plus ultraviolet A radiation.
    Ullrich SE
    Photodermatol Photoimmunol Photomed; 1991 Jun; 8(3):116-22. PubMed ID: 1839504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photochemotherapy using pyridopsoralens.
    Dubertret L; Averbeck D; Bisagni E; Moron J; Moustacchi E; Billardon C; Papadopoulo D; Nocentini S; Vigny P; Blais J
    Biochimie; 1985; 67(3-4):417-22. PubMed ID: 3899194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Photoinactivation and recovery in skin fibroblasts after formation of mono- and bifunctional adducts by furocoumarins-plus-UVA.
    Pohl J; Christophers E
    J Invest Dermatol; 1980 Oct; 75(4):306-10. PubMed ID: 7430696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The nature and molecular basis of cutaneous photosensitivity reactions to psoralens and coal tar.
    Pathak MA; Joshi PC
    J Invest Dermatol; 1983 Jun; 80 Suppl():66s-74s. PubMed ID: 6854058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Photoprotective effect of a psoralen-UVA-induced tan.
    Gschnait F; Brenner W; Wolff K
    Arch Dermatol Res; 1978 Nov; 263(2):181-8. PubMed ID: 736602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
    Calzavara-Pinton P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of a case of mycosis fungoides and one of parapsoriasis en plaque with topical PUVA using a monofunctional furocoumarin derivative, 4,6,4'-trimethylangelicin.
    Morita A; Takashima A; Nagai M; Dall'Acqua F
    J Dermatol; 1990 Sep; 17(9):545-9. PubMed ID: 2277144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic suppression of contact hypersensitivity in mice by psoralen plus UVA radiation (PUVA).
    Kripke ML; Morison WL; Parrish JA
    J Invest Dermatol; 1983 Aug; 81(2):87-92. PubMed ID: 6223958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psoralens and ocular effects in humans.
    Glew WB; Nigra TP
    Natl Cancer Inst Monogr; 1984 Dec; 66():235-9. PubMed ID: 6531036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.